Thus, besides IG enhancer hijacking through the IGH-MYC translocations, expression of the alternative MYC transcript as well as protein stabilization due to mutations close to phosphorylation regions might be mechanisms to deregulate activity of MYC in BL. The gene discussed is MYC; the disease is Burkitt lymphoma.